APRICUS BIOSCIENCES

Apricus Bio (Nasdaq:APRI) is a pharmaceutical company that has an approved product, Vitaros®, for the treatment of ED. Vitaros® is approved in Europe and Canada and will be commercialized by Apricus’ marketing partners, which include Abbott Laboratories Limited, Takeda Pharmaceuticals International GmbH, Hexal AG (Sandoz), and Bracco SpA. Femprox®, the Company’s product candidate for the treatment of FSAID, has successfully completed a nearly 400-subject proof-of-concept study.

#SimilarOrganizations #People #Financial #Website #More

APRICUS BIOSCIENCES

Social Links:

Linkedin

Twitter

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

1987-01-01

Address:

San Diego, California, United States

Country:

United States

Website Url:

http://www.apricusbio.com

Total Employee:

51+

Status:

Active

Contact:

858-222-8041

Total Funding:

12.3 M USD

Technology used in webpage:

SPF IPv6 ASP.NET IIS DigiCert SSL IIS 8 New Relic IIS 7 Akamai Hosted ASP.NET 2.0

Similar Organizations

iveric-bio-logo

IVERIC bio

IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.

Current Advisors List

wendell-wierenga_image

Wendell Wierenga Member of Board of Directors @ Apricus Biosciences
Board_member

Current Employees Featured

richard-pascoe_image

Richard Pascoe
Richard Pascoe CEO @ Apricus Biosciences
CEO

steve-martin_image

Steve Martin
Steve Martin SVP & CPO @ Apricus Biosciences
SVP & CPO

Stock Details

Company's stock symbol is NASDAQ:APRI

Acquisitions List

Date	Company	Article	Price
2009-12-14	Bio-Quant	Bio-Quant acquired by Apricus Biosciences	N/A

Official Site Inspections

http://www.apricusbio.com

Host Informations
Whois Informations

Loading ...

More informations about "Apricus Biosciences" on Search Engine